Major Rating Factors:
Weak profitability (1.1 on a scale of 0 to 10) with operating losses during 2022. Return on equity has been low, averaging -24.8%. Weak overall results on stability tests (2.3). Fair overall capitalization (4.4) based on mixed results -- excessive policy leverage mitigated by fair risk adjusted capital (moderate loss scenario).
Other Rating Factors:
Good quality investment portfolio (5.7). Excellent Liquidity (8.1).
Stability Factors:
D - Limited diversification of general business, policy, and/or investment risk.
I - Past results on our Investment Safety Index.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Ind health (100.0%)
Licensed in:
All states except CT, FL, MN, NH, NY, RI, SC, WY, PR